NCT01661764View on ClinicalTrials.gov

Fish Oil Supplementation, Nutrigenomics and Colorectal Cancer Prevention

PHASE2CompletedINTERVENTIONAL
Enrollment

141

Participants

Timeline

Start Date

February 4, 2013

Primary Completion Date

December 26, 2016

Study Completion Date

January 23, 2018

Conditions
Colorectal Adenomatous Polyps
Interventions
DRUG

Eicosapentanoic acid and docosahexanoic acid

1395 mg EPA plus 1125 mg DHA daily for 24 weeks

DRUG

Oleic Acid

Placebo

Trial Locations (1)

37232

Vanderbilt University Medical Center, Nashville

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

Vanderbilt University

OTHER

NCT01661764 - Fish Oil Supplementation, Nutrigenomics and Colorectal Cancer Prevention | Biotech Hunter | Biotech Hunter